openPR Recherche & Suche
Pressearchiv

SIRION BIOTECH GmbH

SIRION BIOTECH GmbH

SIRION BIOTECH GmbH Dieter Lingelbach Am Klopferspitz 19 D-82152 Martinsried Tel.: +49-89-700 961 99-14 eMail: Lingelbach@Sirion-Biotech.de www.Sirion-Biotech.com

Über das Unternehmen

SIRION BIOTECH GmbH is a biotech company that produces genetically modified cells and is a tech-nology provider in the area of viral vector systems for gene therapy and vaccine applications. The company was founded in 2006 and is located in Munich with offices in Tokyo and New Hampshire. The expert in RNAi technology offers a wide range of more than 100 products and services. Using state of the art techniques and assay systems the company offers reliable lead-through service pro-jects in target validation, screening and discovery for the drug, food & cosmetic industries.
SIRION BIOTECH currently operates projects for most of the major pharmaceutical companies in Europe and has ongoing collaborations with leading academic and governmental research institutes. Increasingly, clients from Japan and USA are being served.

Aktuelle Pressemitteilungen von SIRION BIOTECH GmbH
SIRION Biotech presents at prestigious World Summit on Innovation in Boston, MA on 26 September 2012
SIRION BIOTECH GmbH

SIRION Biotech presents at prestigious World Summit on Innovation in Boston, MA on 26 September 2012

Munich, Germany, SIRION Biotech is invited to present its business model and its recent history of success at the World Summit on INNOVATION & ENTREPRENEURSHIP in Boston on 26 – 28 Sep-tember 2012: “The Summit sets the scene for some of the world’s eminent dreamers and doers to plot the new frontier of the smarter innovation economy” (http://www.thewsie.org/prologue.html). The World Summit on Innovation & Entrepreneurship was launched in 2006 at the United Nations under the support of three UN agencies, International Chamber of Commerce, Afri…
10.07.2012
1
Sie lesen gerade: SIRION BIOTECH GmbH Presse – Pressemitteilung